Colon Test


 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


 

 

 

 

 

 

 

 

 

 

Peter Drucker:  “When innovating, go with the market response,

not with your preconceived ideas.”

 

ED Doctor Survey Summary

Competitive gFOBT cards vs ColonTest

 

General FOBT Questions
1.  In your opinion, what % of Trauma victims should have an FOBT kit used on them?    8 = 100%, 1 = 25%, 1= 50%
2.  In your opinion, what % of Surgery patients should have a pre-op FOBT kit used on them?

  7 = 100%, 1 = don’t know 

  1 = 25%, 1= 50%

3.  In your opinion, how many non-trauma, nom-surgical patients have an FOBT test performed
on them? 
  Range 10% - 50% Agree
4.  Is Point Of Care (POC) development of FOBT kits in the ED allowed in your hospital?
 50% yes, 50% no, as it depends on hospital
5.  Does the Infection Control Dept. insist on following proper POC FOBT procedures?
100% Yes
6.  Can a billable POC kit developed in the Emergency Department, increase ED revenue?
100% Yes
Existing FOBT Kits in the ED
1.  Do you develop existing FOBT kits on an as needed basis? 
100% Yes
2.  Is your diagnosis ever delayed while waiting for a FOBT developer bottle or Lab results?
100% Yes
3.  Is the quality of your current Guaiac FOBT slides & their developer bottles an issue in the way they are stored & used?
Yes 100%
4.  Is environmental control constantly maintained over developer quality, lot #, mismatch, &/or fecal contamination of lid, bottle & tip?
No 100%
5. Are your existing FOBT kits protected from heat, light and chemical vapors that can inactivate the guaiac card & developer? 90% yes, 10%  I don’t know
6.  Do you apply developer to the Control area and wait for it to turn blue every time? 
100% Yes
7.  Is a Control Area Response test performed on every newly opened box of FOBT?
100% No
8.  Are FOBT slides & developer lot codes matched all the time?   70% No 30% I don’t know
9.  Are hospital rules concerning Point Of Care testing outside of the Lab followed rigorously?

   80% No  10% = Yes,

10%= I don’t know

10.  What bothers you most
about existing FOBT kits?
90% “Can’t find developer, 10% dirty developer bottle
   
ColonTest-Sensitive  in the ED  
1.  Is ColonTest's secure retention of the fecal sample a real benefit? 
100 %Yes
2.  Is ColonTest's developer in a glass ampoule a significant Quality &  Safety improvement?
Yes Overwhelmingly 100%
3.  Does ColonTest's foil pouch offer a Quality & Safety benefit for the ED?
100 %Yes
4.  Is ColonTest likely to reduce ED clinician time in diagnosing patients?
100 %Yes
5.  Is ColonTest likely to improve the quality of fecal blood detection? 
90% Yes, 
10% = I don’t know
6.  Does a billable ColonTest POC FOBT kit represent a benefit for the ED?. 
100 %Yes
7.  Does ColonTest  answer enough ED needs to make it a "must have" product?
100 %Yes
8.  Does ColonTest’s streamlined, cleaner POC FOBT test make you more likely to perform the test?
80% yes,  20 % =
“Would do it anyway”
9.  What do you see as ColonTest's major
benefit in the ED?
 Clean, don’t have
to find developer,
can trust the quality
10.  Do you see any reason ColonTest would NOT be readily adopted in the  ED?
No 100%
11.  After seeing ColonTest-Sensitive, pick your preferred FOBT for the ED:  

1. ColonTest-Sensitive is clearly superior over existing
FOBTs in the ED.       

100% Agree
  2.  “I'll stick with the existing Hemoccult™ slides.”
0%  Hemoccult™
is a trademark of
Beckman Coulter